CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Many viruses circulate seasonally, picking up as the weather cools in the fall and winter. So it’s true that fewer people get ...

The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...

As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans ...

The number of people with COVID-19 in the U.S. is low but increasing, according to Centers for Disease Control and Prevention (CDC) data released Friday.  COVID-19 is trending up in many ...

A new COVID-19 booster vaccine is coming out this fall, but don’t expect many people in Wyoming to get it. That falls in line ...

The study "really underlines how significant the pandemic environment was for mental and neurological health," Mahdi Moqri, a ...

Robert F Kennedy Jr announced that 22 projects, totalling $500m, to develop vaccines using mRNA technology will be halted ...

A group of scientists has confirmed the efficacy of a new oral anti-viral treatment, called CP-COV03 or Xafty, against ...

Only 18.3% of Wisconsinites have received at least one dose of a COVID-19 vaccine for the 2024-2025 season as of Aug. 1, ...

Kennedy’s decision to terminate the projects is the latest in a string of decisions that have put the long-time vaccine ...